Our principal, Ms. Pauli Wong, was invited by HKUST to speak at their Entrepreneurship 101 Training Program on the topic of protecting start-ups through intellectual property. Her talk, titled “Patent 101 for Entrepreneurs and Start-Ups,” covered the fundamentals of IP, with a particular focus on patents. She highlighted often-overlooked aspects and shared invaluable tips to help start-up entrepreneurs avoid common pitfalls.

Pauli really enjoyed giving the talk and felt inspired by the positive feedback from the audience. She found it rewarding to share her knowledge about intellectual property and its importance for entrepreneurs. This experience has motivated her to give more presentations in the future, as she wants to reach more people and help them understand IP better.

On a side note, we want to wish the HKUST Entrepreneurship Center a happy 25th anniversary, which they are celebrating this week!




Our Past Events

Recommended Insights

Foreign companies transferring IP out of China: things to know

25 October 2018
Inventions made in China Most foreign companies with R&D sites in China are aware of the fact that inventors having inventions made in China have to obtain permission before they can file patent applications outside of China for these Chinese inventions. It doesn’t matter if the owner of the business is a foreign entity. Patent […]

Do Promotional Marketing Materials Constitute an “Offer for Sale” under Chinese Patent Law? Bayer IP GmbH v. Nanjing Hang Seng Pharmaceutical

12 December 2023
Bayer's blockbuster drug Rivaroxaban has seen its share of patent litigations in China, several of which are big enough to be listed as Top 10 IP cases or 50 Representative IP cases. We summarized an invalidation case back in 2020 where all of Bayer’s claims directed towards the compound were upheld. Recently, another Rivaroxaban case […]

Is it Sufficient to Claim an Antibody only by Describing its Antigen?

12 November 2018
Things may be brewing with respect to antibody inventions. Just how much description is sufficient? After losing in the Federal Circuit, Amgen has decided to ask the US Supreme Court to weigh in on a standard that could vastly influence the pharmaceutical and biotech industry. The story relates to Repatha™, an LDL-lowering drug from Amgen […]

How Smart is a "Skilled Person in the Art"?

11 April 2022
Let’s start with a riddle: can you name a person who has read every book, every journal, conducted every known experiment, and is knowledgeable about every single patent prosecution / litigation in the world? The answer? A “skilled person in the art.” This person is also known as a “person having ordinary skill in the […]
Top crossarrow-right